Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial
Authors:
Open Access
Abstract
Objective: To determine the efficacy of statin treatment in atrial fibrillation (AF) prevention in women. Design: Cohort study using data obtained in the Heart and Estrogen/Progestin Replacement Study (HERS). Setting: Secondary analysis of a multicentre, randomised controlled clinical trial. Patients: 2673 Postmenopausal women with coronary disease. Main outcome measures: AF prevalence at baseline and incident AF over a mean follow-up of 4.1 years. Results: 88 Women with AF were identified: 29 at baseline and 59 during follow-up. Women with AF were significantly less likely to be taking a statin at study enrolment than those without AF (22% vs 37%, p = 0.003). Baseline statin use was associated with a 65% lower odds of having AF at baseline after controlling for age, race, history of myocardial infarction or revascularisation and history of heart failure (odds ratio 0.35, 95% confidence interval (CI) 0.13 to 0.93, p = 0.04). The risk of developing AF during the study among those free from AF at baseline, adjusted for the same covariates, was 55% less for those receiving statin treatment (hazard ratio 0.45, 95% CI 0.26 to 0.78, p = 0.004). Conclusions: Statin treatment is associated with a lower prevalence and incidence of AF after adjustment for potential confounders in postmenopausal women with coronary disease.Keywords
This publication has 59 references indexed in Scilit:
- Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2008
- Statin use and recurrence of atrial fibrillation after successful cardioversionAmerican Heart Journal, 2007
- Regional left atrial voltage in patients with atrial fibrillationHeart Rhythm, 2007
- Sex-Based Differences in the Effect of Intra-Arterial Treatment of StrokeStroke, 2006
- Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunctionHeart Rhythm, 2006
- Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2006
- Effect of C-reactive protein reduction on paroxysmal atrial fibrillationAmerican Heart Journal, 2005
- Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversionThe American Journal of Cardiology, 2004
- Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial FibrillationStroke, 1999
- Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular functionThe American Journal of Cardiology, 1993